Due to a previous satisfactory response to FVIII/VWF concentrate and contraindication of desmopressin in patients with cardiac insufficiency because of fluid retention [4], FVIII/VWF concentrate was chosen as the treatment of choice to prevent peri- and post-operative bleeding. This evidence concerns the gene VWF and heart failure.